Sittner & Nelson’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Sittner & Nelson's EW Position: Q1 2026 in Review
Sittner & Nelson reduced its Edwards Lifesciences (EW) stake by 1.2% in Q1 2026, selling an estimated $24.7K and leaving 24,275 shares worth $1.94M. The position accounts for 0.71% of the portfolio, ranked #31.
Sittner & Nelson first reported a position in EW in Q4 2020 and has held it in 22 quarters since. The position peaked at $3M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Sittner & Nelson held 24,275 shares of Edwards Lifesciences worth $1.94M as of Q1 2026.
- Sittner & Nelson sold 300 Edwards Lifesciences shares in Q1 2026, an estimated $24.7K.
- Edwards Lifesciences made up 0.71% of Sittner & Nelson's portfolio in Q1 2026, its #31 holding.
- Sittner & Nelson first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 22 quarters since.
- Sittner & Nelson's Edwards Lifesciences position peaked at $3M in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.